Cognitive Experience

powered by Brain Frequency™

Treatment that Heals the Mind

b:Rare Health Cognitive powered by Brain Frequency™ offers a revolutionary treatment that is designed to improve executive function

“I felt a change after the first two treatments and immediately knew this was going to work!”

Linden King

Former NFL Linebacker

Brain Frequency™ identifies the optimal operating frequency unique to each person’s brain, and identifies those areas of the brain functioning below optimal frequency. Using this information, the software recommends a treatment protocol for the Brain Frequency™ provider to consider. By spacing qEEG’s between treatments, the effectiveness of a treatment protocol can be objectively measured, and the provider has a tool to assist with adjustments to the treatment plan.

What can Brain Frequency™ Treat?

Individualized Transcranial Magnetic Stimulation (Brain Frequency™) is a ground-breaking therapeutic approach to improving cognitive function.

Frequently Asked Questions

5-7 days a week of daily treatments is the standard process. If treatment twice a day is approved, there needs to be a three hour break between the first and second treatment. We suggest starting and finishing treatment once you begin.

The number of Brain Frequency™ treatments depends upon the diagnosis, severity of symptoms, and response rate. On average, patients receive once or twice a day treatment 5-7 days per week for at least 4-12 weeks. Some patients report positive results in as few as 4 to 6 treatments.

No. You cannot feel this treatment. You can hear the machine once turned on, as well as a ticking noise, but that is it. Some people report feeling tired after treatment.

Brain Frequency™ is well-tolerated. Few patients discontinue treatment because of side effects. Though the risk is extremely small, there have been a few reports of seizures with TMS devices (1 in 3 million). There are no known adverse cognitive (thinking and memory) effects associated with TMS therapy. Additionally, no known long-term adverse effects have been reported with the use of TMS. However, as a relatively new treatment, unforeseen long-term risks may exist. The risks of exposure to TMS during pregnancy are unknown.

After each qEEG. Progress is tracked through progress reports derived from diagnostic tools and psychometric assessments. This process will occur after every set of 10 treatments. The practitioner will review this progress report with the patient before continuing with another set.​